Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?

Graña-López L, Herranz M, Domínguez-Prado I, Argibay S, Villares Á, Vázquez-Caruncho M.

Eur Radiol. 2019 Aug 2. doi: 10.1007/s00330-019-06356-9. [Epub ahead of print]

PMID:
31375867
2.

Vaginal residence and pharmacokinetic preclinical study of topical vaginal mucoadhesive W/S emulsions containing ciprofloxacin.

Campaña-Seoane M, Pérez-Gago A, Vázquez G, Conde N, González P, Martinez A, Martínez X, García Varela L, Herranz M, Aguiar P, Fernández-Ferreiro A, Laguna R, Otero-Espinar FJ.

Int J Pharm. 2019 Jan 10;554:276-283. doi: 10.1016/j.ijpharm.2018.11.022. Epub 2018 Nov 10.

PMID:
30423417
3.

Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model.

Seoane-Viaño I, Gómez-Lado N, Lázare-Iglesias H, Barreiro-de Acosta M, Silva-Rodríguez J, Luzardo-Álvarez A, Herranz M, Otero-Espinar F, Antúnez-López JR, Lamas MJ, Aguiar P, Fernández-Ferreiro A, Ruibal Á.

Int J Pharm. 2018 Oct 5;549(1-2):335-342. doi: 10.1016/j.ijpharm.2018.08.005. Epub 2018 Aug 3.

PMID:
30081226
4.

Preclinical characterization and clinical evaluation of tacrolimus eye drops.

Luaces-Rodríguez A, Touriño-Peralba R, Alonso-Rodríguez I, García-Otero X, González-Barcia M, Rodríguez-Ares MT, Martínez-Pérez L, Aguiar P, Gómez-Lado N, Silva-Rodríguez J, Herranz M, Ruibal-Morell Á, Lamas MJ, Otero-Espinar FJ, Fernández-Ferreiro A.

Eur J Pharm Sci. 2018 Jul 30;120:152-161. doi: 10.1016/j.ejps.2018.04.038. Epub 2018 Apr 26.

PMID:
29705214
5.

Ophthalmic Econazole Hydrogels for the Treatment of Fungal Keratitis.

Díaz-Tomé V, Luaces-Rodríguez A, Silva-Rodríguez J, Blanco-Dorado S, García-Quintanilla L, Llovo-Taboada J, Blanco-Méndez J, García-Otero X, Varela-Fernández R, Herranz M, Gil-Martínez M, Lamas MJ, González-Barcia M, Otero-Espinar FJ, Fernández-Ferreiro A.

J Pharm Sci. 2018 May;107(5):1342-1351. doi: 10.1016/j.xphs.2017.12.028. Epub 2018 Jan 3.

PMID:
29305870
6.

Texture analysis of high-resolution dedicated breast 18 F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer.

Moscoso A, Ruibal Á, Domínguez-Prado I, Fernández-Ferreiro A, Herranz M, Albaina L, Argibay S, Silva-Rodríguez J, Pardo-Montero J, Aguiar P.

Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):196-206. doi: 10.1007/s00259-017-3830-1. Epub 2017 Sep 21.

PMID:
28936601
7.

Cysteamine polysaccharide hydrogels: Study of extended ocular delivery and biopermanence time by PET imaging.

Luaces-Rodríguez A, Díaz-Tomé V, González-Barcia M, Silva-Rodríguez J, Herranz M, Gil-Martínez M, Rodríguez-Ares MT, García-Mazás C, Blanco-Mendez J, Lamas MJ, Otero-Espinar FJ, Fernández-Ferreiro A.

Int J Pharm. 2017 Aug 7;528(1-2):714-722. doi: 10.1016/j.ijpharm.2017.06.060. Epub 2017 Jun 19.

PMID:
28634142
8.

Preclinical PET Study of Intravitreal Injections.

Fernández-Ferreiro A, Luaces-Rodríguez A, Aguiar P, Pardo-Montero J, González-Barcia M, García-Varela L, Herranz M, Silva-Rodríguez J, Gil-Martínez M, Bermúdez MA, Vieites-Prado A, Blanco-Méndez J, Lamas MJ, Gómez-Ulla F, Ruibal Á, Otero-Espinar FJ, González F.

Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):2843-2851. doi: 10.1167/iovs.17-21812.

PMID:
28570736
9.

In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan.

Fernández-Ferreiro A, Silva-Rodríguez J, Otero-Espinar FJ, González-Barcia M, Lamas MJ, Ruibal A, Luaces-Rodríguez A, Vieites-Prado A, Lema I, Herranz M, Gómez-Lado N, Blanco-Mendez J, Gil-Martínez M, Pardo M, Moscoso A, Cortes J, Sánchez-Martínez M, Pardo-Montero J, Aguiar P.

Eur J Pharm Biopharm. 2017 May;114:317-323. doi: 10.1016/j.ejpb.2017.01.023. Epub 2017 Feb 9.

PMID:
28189624
10.

Positron Emission Tomography for the Development and Characterization of Corneal Permanence of Ophthalmic Pharmaceutical Formulations.

Fernández-Ferreiro A, Silva-Rodríguez J, Otero-Espinar FJ, González-Barcia M, Lamas MJ, Ruibal A, Luaces-Rodriguez A, Vieites-Prado A, Sobrino T, Herranz M, García-Varela L, Blanco-Mendez J, Gil-Martínez M, Pardo M, Moscoso A, Medín-Aguerre S, Pardo-Montero J, Aguiar P.

Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):772-780. doi: 10.1167/iovs.16-20766.

PMID:
28146242
11.

Clinicopathological characteristics of infiltrating lobular breast carcinoma in elderly women: Preliminary results.

Ruibal A, Aguiar P, Del Camen Del Río M, Menéndez P, Arias JI, Herranz M.

Mol Clin Oncol. 2015 Nov;3(6):1337-1340. Epub 2015 Aug 28.

12.

Cell membrane CD44v6 levels in squamous cell carcinoma of the lung: association with high cellular proliferation and high concentrations of EGFR and CD44v5.

Ruibal Á, Aguiar P, Del Río MC, Nuñez MI, Pubul V, Herranz M.

Int J Mol Sci. 2015 Feb 18;16(3):4372-8. doi: 10.3390/ijms16034372.

13.

In vivo quantification of renal function in mice using clinical gamma cameras.

Silva-Rodríguez J, Cortés J, Pardo-Montero J, Pérez-Fentes D, Herranz M, Ruibal Á, Aguiar P.

Phys Med. 2015 May;31(3):242-7. doi: 10.1016/j.ejmp.2015.01.013. Epub 2015 Feb 26.

PMID:
25726477
14.

Histological grade (HG) in invasive ductal carcinomas of the breast of less than 1 cm: clinical and biological associations during progression from HG1 to HG3.

Ruibal Á, Aguiar P, Del Rio MC, Arias JI, Menéndez-Rodríguez P, Gude F, Herranz M.

Anticancer Res. 2015 Jan;35(1):569-73.

PMID:
25550604
15.

The contrasting epigenetic role of RUNX3 when compared with that of MGMT and TIMP3 in glioblastoma multiforme clinical outcomes.

Saraiva-Esperón U, Ruibal A, Herranz M.

J Neurol Sci. 2014 Dec 15;347(1-2):325-31. doi: 10.1016/j.jns.2014.10.043. Epub 2014 Nov 7.

PMID:
25467143
16.

CA15.3 serum concentrations in older women with infiltrating ductal carcinomas of the breast.

Ruibal Á, Aguiar P, Del Río MC, Padín-Iruegas ME, Arias JI, Herranz M.

Int J Mol Sci. 2014 Oct 31;15(11):19870-6. doi: 10.3390/ijms151119870.

17.

Positive immunohistochemical expression of bcl-2 in hormone-independent breast carcinomas is associated with a greater lymph node involvement and poor outcome.

Ruibal Á, Aguiar P, Del Río MC, Menéndez P, Arias JI, Herranz M.

Med Oncol. 2014 Aug;31(8):105. doi: 10.1007/s12032-014-0105-6. Epub 2014 Jul 10.

PMID:
25008065
18.

A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer.

Barh D, Jain N, Tiwari S, Field JK, Padin-Iruegas E, Ruibal A, López R, Herranz M, Bhattacharya A, Juneja L, Viero C, Silva A, Miyoshi A, Kumar A, Blum K, Azevedo V, Ghosh P, Liloglou T.

BMC Genomics. 2013;14 Suppl 6:S5. doi: 10.1186/1471-2164-14-S6-S5. Epub 2013 Oct 25.

19.
20.

Optical imaging in breast cancer diagnosis: the next evolution.

Herranz M, Ruibal A.

J Oncol. 2012;2012:863747. doi: 10.1155/2012/863747. Epub 2012 Dec 4.

Supplemental Content

Loading ...
Support Center